Yes. If I may add to that, I also feel that, oftentimes—and I believe, Pnina, you spoke to this—women are misdiagnosed. They are showing up with symptoms that are a result of perimenopause and menopause but they're not being recognized as such, so they are being prescribed SSNRIs and anti-anxiety and depression medication, when, in fact, hormone therapy, started earlier, would have been the right first line of defence. Because there's not enough research in the actual symptoms and the linkage to perimenopause and menopause during that hormonal transition, the actual prescribing of treatment is inaccurate to begin with.
Also, I would say that insurance companies are reluctant to carry treatments for menopause and perimenopause because of the costs associated. However, the costs associated with short-term and long-term disability are actually much greater and are a much larger risk. There are very much limited research studies on the long-term safety and effectiveness of hormone therapy. There's also a lot of research emerging showing that it's highly beneficial for other areas in the long-term life of women, such as Alzheimer's and dementia.
We just do not know enough about the effectiveness of the treatments due to the efficacy gap. Things have not been treated on women or tested on women to begin with, and therefore are misdiagnosed, misunderstood and misinformed. This is a root problem beginning with research and data that's disaggregated by sex.
